Clinical Trial Update: A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma [Phase 2]

View source ↗

Summary

A Phase II study evaluates Gliadel wafers with temozolomide and radiation, followed by dose-dense temozolomide plus bevacizumab, for newly diagnosed malignant h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma
• High-grade Glioma

Drugs mentioned

• Avastin (bevacizumab)
• GLIADEL (Carmustine)
• Temodar (Temozolomide)

Snippet

Sponsor: Kentuckiana Cancer Institute | Conditions: Glioma | Phase 2 | Status: UNKNOWN